Suven Pharmaceuticals Q2 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
623-6.90 (-1.10%)
Volume6.51 K
Updated: Wed 22 May, 2024 | 15:29:55
NSE
620.55-9.95 (-1.58%)
Volume1.67 L
Updated: Wed 22 May, 2024 | 15:32:31
Today: 605.00
628.60
52-Wk: 427.05
767.00

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 231.05347.55-33.52%
    Selling/ General/ Admin Expenses Total 28.5828.74-0.58%
    Depreciation/ Amortization 11.8912.54-5.18%
    Other Operating Expenses Total 13.1616.21-18.79%
    Total Operating Expense 144.98193.13-24.93%
    Operating Income 86.07154.42-44.26%
    Net Income Before Taxes 105.41163.94-35.70%
    Net Income 79.56120.59-34.02%
    Diluted Normalized EPS 3.134.74-33.97%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App